Newsroom

U.S. NEWS & WORLD REPORT NAMES HOUSTON METHODIST HOSPITAL TO HONOR ROLL FOR FOURTH TIME

U.S. News & World Report has named Houston Methodist Hospital to its top ranked Honor Roll for the fourth time and second consecutive year. Read More

Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective

Principal investigator Eric Salazar, M.D., Ph.D., oversees work being done in the convalescent plasma research lab.

A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective. Read more

Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving

Houston Methodist physician scientists (left to right) Eric Salazar, MD, PhD, and James M. Musser, MD, PhD, discuss their convalescent plasma trial for treating COVID-19, the results of which were the first in the U.S. to be peer-reviewed and published.
The country’s first convalescent plasma transfusion trial results have been peer-reviewed and published, showing 19 out of 25 patients improving with the treatment and 11 discharged from the hospital. Read more

Latest News

Tuesday, September 8, 2020 'Large-scale' distribution of COVID vaccine by November: Houston top doc weighs in on CDC's plan
Read more
Friday, August 28, 2020 Hispanic teens in Houston being hit hard by COVID, new data shows
Read more
Sunday, August 23, 2020 Houston health institutions enrolling COVID patients in rigorous plasma studies
Read more
View All News & Events

Need to Reach a PR Representative?

Please call a media relations representative at 713.790.2201

See Media Contacts